The Impact of Expedited Review Status on Biomanufacturing Facility Design.
| Publicado en: | BioPharm International Vol. 32; no. 1; pp. 37 - 41 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Jan2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134257358&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 134257358 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Jan2019 vid: 32 iid: 1 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 134257358 134257358 ppf: 37 ppct: 4 formats: fmt: @attributes: type: P tig: atl: The Impact of Expedited Review Status on Biomanufacturing Facility Design. aug: au: ODUM, JEFF affil: Principal at NCBiosource sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|